Cargando…

ETS transcription factor ERG cooperates with histone demethylase KDM4A

ERG (ETS-related gene) is a member of the ETS (erythroblast transformation-specific) family of transcription factors. Overexpression of the ERG transcription factor is observed in half of all prostate tumors and is an underlying cause of this disease. However, the mechanisms involved in the function...

Descripción completa

Detalles Bibliográficos
Autores principales: KIM, TAE-DONG, SHIN, SOOK, JANKNECHT, RALF
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869937/
https://www.ncbi.nlm.nih.gov/pubmed/27109047
http://dx.doi.org/10.3892/or.2016.4747
_version_ 1782432388174839808
author KIM, TAE-DONG
SHIN, SOOK
JANKNECHT, RALF
author_facet KIM, TAE-DONG
SHIN, SOOK
JANKNECHT, RALF
author_sort KIM, TAE-DONG
collection PubMed
description ERG (ETS-related gene) is a member of the ETS (erythroblast transformation-specific) family of transcription factors. Overexpression of the ERG transcription factor is observed in half of all prostate tumors and is an underlying cause of this disease. However, the mechanisms involved in the functions of ERG are still not fully understood. In the present study, we showed that ERG can directly bind to KDM4A (also known as JMJD2A), a histone demethylase that particularly demethylates lysine 9 on histone H3. ERG and KDM4A cooperated in upregulating the promoter of Yes-associated protein 1 (YAP1), a downstream effector in the Hippo signaling pathway and crucial growth regulator. Multiple ERG binding sites within the human YAP1 gene promoter were identified and their impact on transcription was determined through mutational analysis. Furthermore, we found that ERG expression reduced histone H3 lysine 9 trimethylation at the YAP1 gene promoter, consistent with its epigenetic regulation through the ERG interaction partner, KDM4A. Finally, downregulation of YAP1 phenocopied the growth-retarding effect of ERG or KDM4A depletion in human VCaP prostate cancer cells. Collectively, these results elucidated a novel mechanism - ERG promotes prostate tumorigenesis together with KDM4A through the upregulation of YAP1. A corollary is that KDM4A as well as YAP1 inhibitors may prove beneficial for the therapy of ERG-overexpressing prostate tumors.
format Online
Article
Text
id pubmed-4869937
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-48699372016-05-20 ETS transcription factor ERG cooperates with histone demethylase KDM4A KIM, TAE-DONG SHIN, SOOK JANKNECHT, RALF Oncol Rep Articles ERG (ETS-related gene) is a member of the ETS (erythroblast transformation-specific) family of transcription factors. Overexpression of the ERG transcription factor is observed in half of all prostate tumors and is an underlying cause of this disease. However, the mechanisms involved in the functions of ERG are still not fully understood. In the present study, we showed that ERG can directly bind to KDM4A (also known as JMJD2A), a histone demethylase that particularly demethylates lysine 9 on histone H3. ERG and KDM4A cooperated in upregulating the promoter of Yes-associated protein 1 (YAP1), a downstream effector in the Hippo signaling pathway and crucial growth regulator. Multiple ERG binding sites within the human YAP1 gene promoter were identified and their impact on transcription was determined through mutational analysis. Furthermore, we found that ERG expression reduced histone H3 lysine 9 trimethylation at the YAP1 gene promoter, consistent with its epigenetic regulation through the ERG interaction partner, KDM4A. Finally, downregulation of YAP1 phenocopied the growth-retarding effect of ERG or KDM4A depletion in human VCaP prostate cancer cells. Collectively, these results elucidated a novel mechanism - ERG promotes prostate tumorigenesis together with KDM4A through the upregulation of YAP1. A corollary is that KDM4A as well as YAP1 inhibitors may prove beneficial for the therapy of ERG-overexpressing prostate tumors. D.A. Spandidos 2016-06 2016-04-15 /pmc/articles/PMC4869937/ /pubmed/27109047 http://dx.doi.org/10.3892/or.2016.4747 Text en Copyright © 2016, Spandidos Publications
spellingShingle Articles
KIM, TAE-DONG
SHIN, SOOK
JANKNECHT, RALF
ETS transcription factor ERG cooperates with histone demethylase KDM4A
title ETS transcription factor ERG cooperates with histone demethylase KDM4A
title_full ETS transcription factor ERG cooperates with histone demethylase KDM4A
title_fullStr ETS transcription factor ERG cooperates with histone demethylase KDM4A
title_full_unstemmed ETS transcription factor ERG cooperates with histone demethylase KDM4A
title_short ETS transcription factor ERG cooperates with histone demethylase KDM4A
title_sort ets transcription factor erg cooperates with histone demethylase kdm4a
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869937/
https://www.ncbi.nlm.nih.gov/pubmed/27109047
http://dx.doi.org/10.3892/or.2016.4747
work_keys_str_mv AT kimtaedong etstranscriptionfactorergcooperateswithhistonedemethylasekdm4a
AT shinsook etstranscriptionfactorergcooperateswithhistonedemethylasekdm4a
AT janknechtralf etstranscriptionfactorergcooperateswithhistonedemethylasekdm4a